Skip to main content

Stroke in Pregnancy

  • Chapter
  • First Online:

Abstract

Pregnancy confers an increased risk of both ischemic and hemorrhagic stroke, and, though uncommon, pregnancy-associated stroke is an important cause of long-term disability in young women. This chapter begins with a brief review of the physiologic and pathophysiologic features of pregnancy that contribute to stroke risk and the epidemiology of different types of stroke in pregnancy. It then moves to diagnosis and therapy. Because physicians who do not routinely treat pregnant women may shy away from decision-making due to concern for risk, it is important to emphasize the options for rapid imaging diagnosis during pregnancy. Stroke therapies have expanded greatly in recent years, and their applications demands rapid action. To provide pregnant women with the fullest opportunity to benefit from such advances, it is critical that physicians be aware of the potential therapies and their availability during pregnancy and the puerperium.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   79.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Feske SK, Klein AM. Neurology of pregnancy and the puerperium. In: Schapira A, editor. Neurology and clinical neuroscience. 1st ed. Philadelphia: Mosby Elsevier; 2007. p. 1490–503.

    Google Scholar 

  2. Feske SK, Singhal A. Cerebrovascular disorders complicating pregnancy. Continuum. 2014;20:80–99.

    PubMed  Google Scholar 

  3. Clark P, Brennand J, Conkie JA, et al. Activated protein C sensitivity, protein C, protein S, and coagulation in normal pregnancy. Thromb Haemost. 1998;79:1166–70.

    Article  CAS  Google Scholar 

  4. Wickström K, Edelstam G, Löwbeer CH, Hansson LO, Sieghahn A. Reference intervals for plasma levels of fibrinogen, von Willebrand factor, free protein S and antithrombin during third-trimester pregnancy. Scand J Clin Lab Invest. 2004;64:31–40.

    Article  Google Scholar 

  5. Kamel H, Navi BB, Sriram N, Hovsepian DA, Devereux RB, Elkind MSV. Risk of thrombotic event after the 6-week postpartum period. N Engl J Med. 2014;370:1307–15.

    Article  CAS  Google Scholar 

  6. Cerneca F, Ricci G, Simeone R, et al. Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Eur J Obstet Gynecokl Reprod Biol. 1997;73:31–6.

    Article  CAS  Google Scholar 

  7. Kittner SJ, Stern BJ, Feeser BR, et al. Pregnancy and the risk of stroke. N Engl J Med. 1996;335:768–74.

    Article  CAS  Google Scholar 

  8. Petitti DB, Sidney S, Quesenberry CP Jr, Bernstein A. Incidence of stroke and myocardial infarction in women of reproductive age. Stroke. 1997;28:280–3.

    Article  CAS  Google Scholar 

  9. Ban L, Sprigg N, Abdul Sultan A, et al. Incidence of first stroke in pregnant and nonpregnant women of childbearing age: a population-based cohort study from England. J Am Heart Assoc. 2017;6:e004601.

    Article  Google Scholar 

  10. Sharshar T, Lamy C, Mas JL, Stroke in Pregnancy Study Group. Incidence and causes of strokes associated with pregnancy and puerperium: a study in public hospitals of Ile de France. Stroke. 1995;26:930–6.

    Article  CAS  Google Scholar 

  11. Jeng JS, Tang SC, Yip PK. Incidence and etiologies of stroke during pregnancy adn puerperium as evidenced in Taiwanese women. Cerebrovasc Dis. 2004;18:290–5.

    Article  Google Scholar 

  12. Kuklina EV, Tong X, Bansil P, George MG, Callaghan WM. Trends in pregnancy hospitalizations that included a stroke in the United States from 1994 to 2007: reasons for concern? Stroke. 2011;42:2564–70.

    Article  Google Scholar 

  13. Chansakul T, Young GS. Neuroimaging in pregnant women. Semin Neurol. 2017;37:712–23.

    Article  Google Scholar 

  14. Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018;49:e46.

    Article  Google Scholar 

  15. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1996;333:1581–7.

    Google Scholar 

  16. Hacke W, Kaste M, Bluhmki E, ECASS Investigators, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317–29.

    Article  CAS  Google Scholar 

  17. Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372:11–20.

    Article  Google Scholar 

  18. Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372:1019–30.

    Article  CAS  Google Scholar 

  19. Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372:1009–18.

    Article  CAS  Google Scholar 

  20. Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015;372:2285–95.

    Article  CAS  Google Scholar 

  21. Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372:2296–306.

    Article  CAS  Google Scholar 

  22. Bracard S, Ducrocq X, Mas JL, et al. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurol. 2016;15:1138–47.

    Article  CAS  Google Scholar 

  23. Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378:11–21.

    Article  Google Scholar 

  24. Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med. 2018;378:708–18.

    Article  Google Scholar 

  25. Altman D, Carroli G, Duley L, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The magpie trial: a randomised placebo-controlled trial. Lancet. 2002;359:1877–90.

    Article  Google Scholar 

  26. The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclampsia trial. Lancet. 1995;345:1455–63.

    Article  Google Scholar 

  27. Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med. 1995;333:201–5.

    Article  CAS  Google Scholar 

  28. Dias MS, Sekhar LN. Intracranial hemorrhage from aneurysms and arteriovenous malformations during pregnancy and the puerperium. Neurosurgery. 1990;27:855–65, discussion 865–856.

    Article  CAS  Google Scholar 

  29. Einhäupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venus thrombosis. Lancet. 1991;338:597–600.

    Article  Google Scholar 

  30. de Bruijn SFTM, Starn J, for the Cerebral Venous Sinus Thrombosis Study Group. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke. 1999;30:484–8.

    Article  Google Scholar 

  31. Lamy C, Hamon JB, Coste J, Mas JL. Iachemic stroke in young women: risk of recurrence during subsequent pregnancies. Neurology. 2000;55:269–74.

    Article  CAS  Google Scholar 

  32. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet. 1994;343:619–29.

    Article  Google Scholar 

  33. Bujold E, Roberge S, Lacasse Y, et al. Prevention of preeclampsia and intrauterine growth retardation with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol. 2010;116:402–14.

    Article  Google Scholar 

  34. Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F, Investigators I. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35:664–70.

    Article  Google Scholar 

  35. Bushnell C, McCullough LD, Awad IA, et al. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:1545–88.

    Article  Google Scholar 

  36. Dentali F, Poli D, Sconditti U, CErebral VEin Thrombosis International Study Investigators, et al. Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study [published correction appears in J Thromb Haemost 2013;11:3991]. J Thromb Haemost. 2012;10:1297–302.

    Article  CAS  Google Scholar 

  37. Saposnik G, Barinagarrementeria F, Brown RD, American Heart Association Stroke Council and the Council on Epidemiology and Prevention, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:1158–92.

    Article  Google Scholar 

  38. Dapprich M, Boessenecker W. Fibrinolysis with alteplase in a pregnant woman with stroke. Cerebrovasc Dis. 2002;13:290.

    Article  Google Scholar 

  39. Wiese KM, Talkad A, Mathews M, Wang D. Intravenous recombinant tissue plasminogen activator in a pregnant woman with cardioembolic stroke. Stroke. 2006;37:2168–9.

    Article  CAS  Google Scholar 

  40. Leonhardt G, Gaul C, Nietsch HH, Buerke M. Thrombolytic therapy in pregnancy. J Thromb Thrombolysis. 2006;21:271–6.

    Article  Google Scholar 

  41. Murugappan A, Coplin WM, Al-Sadat AN, et al. Thrombolytic therapy of acute ischemic stroke during pregnancy. Neurology. 2006;66:768–70.

    Article  CAS  Google Scholar 

  42. Yamaguchi Y, Kondo T, Ihara M, et al. Intravenous recombinant tissue plasminogen activator in an 18-weeks pregnant woman with embolic stroke. Clin Neurol. 2010;50:315–9.

    Google Scholar 

  43. Hori H, Yamamoto F, Ito Y, Hashimoto Y, Hirano T, Uchino M. Intravenous recombinant tissue plasminogen activator therapy in a 14-week pregnant woman with embolic stroke due to protein S deficiency. Rinsho Shinkeigaku. 2013;53:212–6.

    Article  Google Scholar 

  44. Tassi R, Acampa M, Marotta G, et al. Systemic thrombolysis for stroke in pregnancy. Am J Emerg Med. 2013;31:448e441–3.

    Google Scholar 

  45. Ritter LM, Schüler A, Gangopadhyay R, et al. Successful thrombolysis of stroke with intravenous alteplase in the third trimester of pregnancy. J Neurol. 2014;26:632–4.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Steven K. Feske .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Feske, S.K. (2019). Stroke in Pregnancy. In: O’Neal, M. (eds) Neurology and Psychiatry of Women. Springer, Cham. https://doi.org/10.1007/978-3-030-04245-5_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-04245-5_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-04244-8

  • Online ISBN: 978-3-030-04245-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics